Butyrate-producing Faecalibacterium prausnitzii suppresses natural killer/T-cell lymphoma by dampening the JAK-STAT

Zhuangzhuang Shi1, Min Li2, Chen Zhang3,4,5

  • 1Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.

Gut
|December 9, 2024
PubMed
Abstract

Insights

Reduced Faecalibacterium prausnitzii in the gut microbiome is linked to poorer outcomes in natural killer/T-cell lymphoma (NKTCL). Restoring this bacterium may offer a novel therapeutic strategy for NKTCL patients.

Area of Science:

  • Oncology
  • Microbiome research
  • Immunology

Background:

  • Natural killer/T-cell lymphoma (NKTCL) is an aggressive cancer with poor prognosis.
  • Understanding factors influencing NKTCL outcomes is crucial.

Purpose of the Study:

  • To characterize gut microbiota in NKTCL patients.
  • To identify potential probiotic targets for NKTCL treatment.

Main Methods:

  • Shotgun metagenomic sequencing of gut microbiota in Chinese and Korean NKTCL cohorts.
  • Analysis of associations between microbial species and patient survival.
  • In vivo and in vitro studies to assess antitumour effects of F. prausnitzii and its metabolite, butyrate.

Main Results:

  • Significant gut microbiota dysbiosis observed in NKTCL patients, with reduced Faecalibacterium prausnitzii correlating with shorter survival.
  • F. prausnitzii demonstrated antitumour properties in NKTCL models, inhibiting cancer cell growth.
  • Butyrate, a metabolite of F. prausnitzii, suppressed NKTCL progression by inhibiting the JAK-STAT pathway via enhanced histone acetylation and increased SOCS1 expression.

Conclusions:

  • NKTCL exhibits a distinct gut microbiota profile.
  • Faecalibacterium prausnitzii and its metabolite butyrate show therapeutic potential for NKTCL.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.2K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.7K